Company / Financials
Chemed Corp. Financials
FY2010-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.5B
FY2025 · +4.1% YoY
Net Income
$265.2M
FY2025 · -12.2% YoY
Profit Margin
10.5%
FY2025 · net income / revenue
ROE
27.1%
FY2025 · return on equity
Total Assets
$1.5B
FY2025
Total Debt
-
FY2025
Equity
$979.4M
FY2025
ROA
17.2%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.5B+4.1% YoYNet Income HistoryProfit after all expenses and taxes$265.2M-12.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$1.7B+8.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes$338.2M-7.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$417.2M-1.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.8M-1.7% YoYIncome Tax HistoryTotal income tax expense$90.5M-7.1% YoYEPS (Basic) HistoryBasic earnings per share$18.11+8.3% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$17.93+8.5% YoYShares Outstanding HistoryWeighted average diluted shares outstanding15.2M+0.7% YoY